Daily FNArena News

Deutsche Bank believes the RBNZ will tighten at the end of this month while the RBA will sit tight in February. Time to take notice?

Peptech is likely to use the sale proceeds from its Domantis asset to acquire additional antibody technologies, which Intersuisse suggests justifies a Speculative Buy rating.

November retail sales were slightly below market expectations, but strong enough to suggest Australia’s economy remains on a solid footing.

The latest update on Australia’s retail sales by the ABS has generated another estimated 0.4% growth for November last year. It would appear that Canberra in particular is doing well.

ABN Amro has initiated coverage on Mortgage Choice with a Buy rating based on forecast solid earnings growth and an attractive dividend yield.

While housing data for November was slightly stronger than expected the three interest rate increases last year continue to impact on the health of the market.

January tends to be a positive month for shares in general as well as for the US dollar, aluminium and oil, Barclays reports.

The trend seems to have reversed for major newspapers, but the same applies to the internet, ANZ believes.

ABN Amro Morgans believes Avexa shares should be a good way to start the new year with the share price expected to rise strongly between now and March.

The final musings from your editor in 2006. Best wishes to you all.